Phase 2 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults (both men and women) who are obese with a body mass index (BMI) between 32 and 42
- People who have a blood test result showing raised levels of a marker called hsCRP, which indicates ongoing inflammation in the body
- People who have at least one risk factor for heart disease or a cluster of conditions known as metabolic syndrome (such as high blood sugar, high blood pressure, or excess waist fat)
- People who are on stable ongoing treatments and are willing to keep their diet and exercise habits consistent throughout the study
Who may not be able to join:
- People who have Type 1 diabetes
- People who have Type 2 diabetes that is not well controlled
- People with high blood pressure or high cholesterol that is not well controlled
- People whose weight has changed by 5% or more recently
- People who are currently using weight-loss medications or taking part in a weight-loss program
- People with a serious medical condition that could put them at risk or make the study difficult to carry out or assess (confirm with trial site)
- People with significant abnormalities in their heart rhythm or electrical activity, as detected by a heart tracing test (ECG)
- People taking certain medications that are not permitted in this trial, including GLP-1 therapies (such as some diabetes or weight-loss injections), immune-suppressing drugs, long-term anti-inflammatory medications, or certain drugs that affect how the body processes other medicines
- People for whom an MRI scan would not be safe or suitable
- People with a significant problem affecting how their stomach empties, those taking medications that affect gut movement, those who have had weight-loss surgery (such as gastric bypass or other bariatric procedures), or those who have had a device-based or endoscopic treatment for obesity
- Women who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 866-521-2210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent change in hsCRP (Dose A); Percent change in hsCRP (Dose B); Percent change in hsCRP (Dose C)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.